tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

TATA Health Delays 2024 Annual Results Amid Typhoon Disruptions

Story Highlights
TATA Health Delays 2024 Annual Results Amid Typhoon Disruptions

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

TATA Health International Holdings Ltd. ( (HK:1255) ) just unveiled an update.

TATA Health International Holdings Limited has announced a further delay in the publication of its 2024 Annual Results and the dispatch of the 2024 Annual Report due to disruptions caused by super typhoon Ragasa. Consequently, the Board meeting to consider and approve the 2024 Annual Results and any potential annual dividend has been postponed to September 26, 2025. Trading in the company’s shares remains suspended as the company works towards fulfilling resumption guidance, and stakeholders are advised to exercise caution.

More about TATA Health International Holdings Ltd.

Technical Sentiment Signal: Sell

Current Market Cap: HK$72.85M

For a thorough assessment of 1255 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1